Michigan Institute for Neurological Disorders is a clinical research site located in Farmington Hills, Michigan, United States 48334.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Michigan Institute for Neurological Disorders has participated in 16 clinical trials with 3 currently active.
Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Relapsing Multiple Sclerosis.
Sponsors: Genentech, Inc., Hoffmann-La Roche, Innodem Neurosciences.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Michigan Institute for Neurological Disorders has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Michigan Institute for Neurological Disorders has 16 clinical trials on record, with 3 currently active. Their work covers Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Relapsing Multiple Sclerosis.
Yes — Michigan Institute for Neurological Disorders holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.